- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 1.93M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.92M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.92M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $79.73K |
| Capex | Q1 2026 · Mar 31, 2025 | $349.88K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$325.71K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.65M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $13.14M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $11.87M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $16.16M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $17.28M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $44.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $43.91M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $53.84M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $53.93M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $50.94M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $51.54M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $68.15M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $69.54M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.50 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.50 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.33 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.35M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.7M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $282.61K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $316.73K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$969.41K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$629.09K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$691.41K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.28M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $8.16M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $8.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $22.34M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $24.31M |
| Revenue | Q1 2026 · Mar 31, 2026 | $30.5M |
| Revenue | Q1 2026 · Mar 31, 2025 | $33.21M |